RE: Still here....6 Sep 2016 19:56
Not so sure, it's only just over two months since the last update and results. More tests and field trials where needed so earliest would be year end. Bear in mind the potential market? It's worth having £10k in here just to punt the potential.
200 million tests at $5 a sample! Plus no one else in the market. Biggest challenge is its not complete before something else comes along
In our trading update of 21 April 2016 we mentioned a shifting of the needle away from being a biological challenge to an engineering challenge. Subsequently, we have further improved our chances of success by demonstrating elimination of the ambient temperature effect with a test design that requires no engineering modification for field use because it does not require off-line sample treatment. This new design has been tested internally and shows no temperature effect over the range 20-35°C. We are currently now undertaking testing at a local hospital site with patient samples. We have also been able to undertake certain pre-verification studies in order to reduce risks beyond a successful optimisation outcome. Field trials will follow completion of the verification and validation phase, which would then lead to a market launch.
We have also continued to assess the potential market for this product and we have concluded that:
· a large unmet market need still exists for this test; and